Kaur Parminder, Kundra Tanveer Singh, Sood Dinesh
Department of Critical Care, Sir Ganga Ram Hospital, New Delhi, India.
Department of Anesthesia, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India.
J Anaesthesiol Clin Pharmacol. 2017 Jul-Sep;33(3):387-390. doi: 10.4103/joacp.JOACP_18_16.
Intravenous regional anesthesia (IVRA) is a very good technique to be used in unstable patients. Various adjuvants have been added, but till date, there is no ideal adjuvant. Clonidine is one of the most widely used adjuvants in IVRA. However, it has many side effects. Hence, the search continues for a better adjuvant. The aim of the present study was to compare the efficacy of clonidine versus MgSO as an adjunct to lignocaine in IVRA for postoperative analgesia and to compare their side effect profile.
This prospective double-blind randomized controlled study was conducted in a tertiary care institute. Forty adult patients were included. Patients were assigned into two groups; Group 1 ( = 20) received 3 mg/kg of 2% lignocaine + 50% MgSO 1.5 g diluted with normal saline to 40 ml. Group 2 ( = 20) received 3 mg/kg of 2% lignocaine + clonidine 150 μg diluted with normal saline to 40 ml. Pain score, time to first rescue analgesic (TTFA), total number of rescue analgesics required, and the side effects of the two drugs were compared for 24 h postoperatively.
The mean TTFA was significantly longer in Group 1 (193.9 ± 38.4 min) than in Group 2 (169.5 ± 33.3 min); < 0.05. The mean number of rescue analgesics required was 1.6 ± 0.7 in Group 1 as compared to 2.1 ± 0.8 in Group 2 ( < 0.05). More serious side effects such as hypotension and bradycardia were noted with clonidine, although all patients experienced transient pain during intravenous injection of MgSO.
MgSO provides better postoperative analgesia as compared to clonidine when used as an adjunct to lignocaine in IVRA with fewer side effects.
静脉区域麻醉(IVRA)是用于不稳定患者的一种非常好的技术。已添加了各种佐剂,但迄今为止,尚无理想的佐剂。可乐定是IVRA中使用最广泛的佐剂之一。然而,它有许多副作用。因此,人们继续寻找更好的佐剂。本研究的目的是比较可乐定与硫酸镁作为利多卡因在IVRA中辅助术后镇痛的疗效,并比较它们的副作用情况。
本前瞻性双盲随机对照研究在一家三级医疗机构进行。纳入40例成年患者。患者被分为两组;第1组(n = 20)接受3mg/kg的2%利多卡因+1.5g 50%硫酸镁用生理盐水稀释至40ml。第2组(n = 20)接受3mg/kg的2%利多卡因+150μg可乐定用生理盐水稀释至40ml。比较术后24小时两组的疼痛评分、首次使用补救镇痛药的时间(TTFA)、所需补救镇痛药的总数以及两种药物的副作用。
第1组的平均TTFA(193.9±38.4分钟)明显长于第2组(169.5±33.3分钟);P<0.05。第1组所需补救镇痛药的平均数量为1.6±0.7,而第2组为2.1±0.8(P<0.05)。尽管所有患者在静脉注射硫酸镁期间均经历短暂疼痛,但可乐定出现了更严重的副作用,如低血压和心动过缓。
在IVRA中,硫酸镁作为利多卡因的辅助用药时,与可乐定相比,能提供更好的术后镇痛效果,且副作用更少。